Literature DB >> 19565503

Role of osteopontin in induction of monocyte chemoattractant protein 1 and macrophage inflammatory protein 1beta through the NF-kappaB and MAPK pathways in rheumatoid arthritis.

Wenxin Zheng1, Runsheng Li, Heng Pan, Dongyi He, Rong Xu, Taylor B Guo, Yajun Guo, Jingwu Z Zhang.   

Abstract

OBJECTIVE: Osteopontin (OPN) is a proinflammatory protein with a critical role in leukocyte migration. Although OPN has been implicated in rheumatoid arthritis (RA), its underlying mechanism remains unknown. In this study, we investigated the role and molecular mechanism of OPN in the induction of 2 key chemokines, monocyte chemoattractant protein 1 (MCP-1) and macrophage inflammatory protein 1beta (MIP-1beta), in RA.
METHODS: Enzyme-linked immunosorbent assay and quantitative polymerase chain reaction were used to determine chemokine expression. Leukocyte migration in the presence of OPN was measured by chemotaxis assay. Signaling and molecular events were analyzed by immunoblotting and chromatin immunoprecipitation.
RESULTS: The effect of OPN on inflammatory cell migration was mediated through its unique property of inducing the expression of MCP-1 and MIP-1beta in CD14+ monocytes. The concentration of OPN was significantly elevated in RA patients and appeared to correlate with the serum levels of inflammation markers and increased expression of MCP-1 or MIP-1beta in monocytes in RA patients. Endogenous production of OPN in RA synovial fluid was attributable to increased production of MCP-1 or MIP-1beta, and this effect could be blocked by an anti-OPN antibody. Furthermore, the structural motif responsible for this property resided within residues 50-83 of human OPN, sparing the known RGD or SVVYGLR sequences. It was evident that the effect of OPN on chemokine expression was mediated through both the NF-kappaB and MAPK pathways, involving the activation of IKKbeta, p38, and JNK.
CONCLUSION: These results support a unique role of OPN in leukocyte migration, in the context of perpetuation of rheumatoid synovitis through the induction of MCP-1 and MIP-1beta.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19565503     DOI: 10.1002/art.24625

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  33 in total

1.  Serum level of osteopontin as an inflammatory marker does not indicate disease activity or responsiveness to therapeutic treatments in patients with rheumatoid arthritis.

Authors:  Hye-In Ji; Sang-Hoon Lee; Ran Song; Hyung-In Yang; Yeon-Ah Lee; Seung-Jae Hong; Somi Kim; Yong-Beom Park; Soo-Kon Lee; Myung Chul Yoo; Kyoung Soo Kim
Journal:  Clin Rheumatol       Date:  2013-09-01       Impact factor: 2.980

2.  Local injury of the endometrium induces an inflammatory response that promotes successful implantation.

Authors:  Yulia Gnainsky; Irit Granot; Paulomi B Aldo; Amihai Barash; Yuval Or; Edna Schechtman; Gil Mor; Nava Dekel
Journal:  Fertil Steril       Date:  2010-03-24       Impact factor: 7.329

3.  Tumor-derived osteopontin isoforms cooperate with TRP53 and CCL2 to promote lung metastasis.

Authors:  Ioanna Giopanou; Ioannis Lilis; Vassilios Papaleonidopoulos; Theodora Agalioti; Nikolaos I Kanellakis; Nikolitsa Spiropoulou; Magda Spella; Georgios T Stathopoulos
Journal:  Oncoimmunology       Date:  2016-11-18       Impact factor: 8.110

4.  Osteopontin can decrease the expression of Col-II and COMP in cartilage cells in vitro.

Authors:  Yingxia Zhang; Tiansheng Wang; Yu Cao
Journal:  Int J Clin Exp Med       Date:  2015-02-15

5.  Induction of monocyte chemoattractant protein-1 by nicotine in pancreatic ductal adenocarcinoma cells: role of osteopontin.

Authors:  Melissa Lazar; Jennifer Sullivan; Galina Chipitsyna; Tamer Aziz; Ahmed F Salem; Qiaoke Gong; Agnes Witkiewicz; David T Denhardt; Charles J Yeo; Hwyda A Arafat
Journal:  Surgery       Date:  2010-06-25       Impact factor: 3.982

6.  The CC chemokine ligand 2 (CCL2) polymorphism -2518A/G is associated with gout in the Chinese Han male population.

Authors:  Ruixia Sun; Keke Zhang; Xiaokun Zhang; Lingling Cui; Can Wang; Qingsheng Mi; Shiguo Liu; Changgui Li
Journal:  Rheumatol Int       Date:  2014-08-14       Impact factor: 2.631

7.  Osteopontin stimulates matrix metalloproteinase expression through the nuclear factor-κB signaling pathway in rat temporomandibular joint and condylar chondrocytes.

Authors:  Feng Ding; Jing Wang; Guoxiong Zhu; Huaqiang Zhao; Gaoyi Wu; Lei Chen
Journal:  Am J Transl Res       Date:  2017-02-15       Impact factor: 4.060

8.  Osteopontin splice variants expressed by breast tumors regulate monocyte activation via MCP-1 and TGF-β1.

Authors:  Jintang Sun; Alei Feng; Songyu Chen; Yun Zhang; Qi Xie; Meixiang Yang; Qianqian Shao; Jia Liu; Qifeng Yang; Beihua Kong; Xun Qu
Journal:  Cell Mol Immunol       Date:  2013-02-18       Impact factor: 11.530

9.  Association of rheumatoid arthritis susceptibility gene with lipid profiles in patients with rheumatoid arthritis.

Authors:  Lisa A Davis; Emily Whitfield; Grant W Cannon; Roger K Wolff; Dannette S Johnson; Andreas M Reimold; Gail S Kerr; J Steuart Richards; Ted R Mikuls; Liron Caplan
Journal:  Rheumatology (Oxford)       Date:  2014-06       Impact factor: 7.580

10.  Blockade of osteopontin reduces alloreactive CD8+ T cell-mediated graft-versus-host disease.

Authors:  Fang Zhao; Yi Zhang; Hao Wang; Min Jin; Shan He; Yufang Shi; Yajun Guo; Yanyun Zhang
Journal:  Blood       Date:  2010-11-30       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.